NBT Bank N A NY Increases Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NBT Bank N A NY boosted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 28.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 2,489 shares of the medical equipment provider's stock after acquiring an additional 544 shares during the quarter. NBT Bank N A NY's holdings in Intuitive Surgical were worth $1,299,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Berbice Capital Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical in the fourth quarter valued at $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical in the fourth quarter valued at $31,000. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical in the third quarter valued at $33,000. Finally, Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical in the fourth quarter valued at $36,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded up $2.78 on Wednesday, hitting $496.50. The company's stock had a trading volume of 1,499,709 shares, compared to its average volume of 1,421,129. The company has a market capitalization of $176.84 billion, a PE ratio of 77.45, a PEG ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock's 50 day moving average is $569.91 and its 200-day moving average is $531.84.

Remove Ads

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,309 shares of company stock worth $7,611,004. Corporate insiders own 0.90% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ISRG shares. Leerink Partners raised their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Raymond James lifted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a "neutral" rating and a $550.00 price target on the stock. Finally, Bernstein Bank lifted their price target on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.